Evaluating Changes in Skeletal Muscle Proteins Following Resistance Exercise and Single-Leg Disuse
1 other identifier
interventional
15
1 country
1
Brief Summary
Skeletal muscle plays a critical role in supporting human health. Beyond its role in providing the force to move, skeletal muscle accounts for a large proportion of metabolic rate, glucose disposal, and amino acid storage. Skeletal muscle is dynamically regulated by environmental stimuli, such as loading (i.e., resistance training\]) and unloading (i.e., disuse atrophy) as well as the intake of essential amino acids (EAAs). However, the precise mechanisms that regulate skeletal muscle mass in response to various conditions (e.g., EAA supplementation, resistance training, and unloading) are not completely understood. Therefore, concerted efforts to better understand the mechanisms regulating skeletal muscle size are needed that aid in the development of therapeutic interventions to combat age, disease, and disuse related muscular atrophy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 16, 2024
CompletedStudy Start
First participant enrolled
April 1, 2024
CompletedFirst Posted
Study publicly available on registry
April 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 11, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 11, 2025
CompletedOctober 1, 2025
October 1, 2024
11 months
January 16, 2024
September 26, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Changes in average rates of muscle synthesis
Skeletal muscle amino acids will be isolated and derivatized. Deuterium enrichment into protein-bound alanine will be measured using Gas chromatography-Pyrolysis-Isotope Ratio Mass Spectrometry
-2, 0 (-4, 0, and 4 hours), and 10 days
Dynamic proteomic profiling
Skeletal muscle lysates containing \~100 ug protein will be digested using sequencing-grade trypsin, and analyzed, via UPLC-QTOF-MS. This will enable the quantification of changes in individual protein abundance, and rates of synthesis and breakdown.
-2, 0, and 10 days
Secondary Outcomes (3)
Protein expression (phosphorylation and content) of novel and known targets implicated in protein translation and mitochondrial-related protein expression
0 (-4, 0, and 4 hours), and 10 days
Muscle torque
-6 and 10 days
Quadriceps skeletal muscle volume
0 and 10 days
Study Arms (2)
Immobilization
EXPERIMENTALParticipants will undergo 10 days of unilateral immobilization whereby a leg will remain in 60 degrees of flexion with the use of a brace. All participants will complete this protocol.
Resistance Training
EXPERIMENTALParticipants will undergo 4 sessions of unilateral resistance training over a 10 day period (the resistance training protocol will include 3 sets of 8-12 reps of leg press and leg extension). All participants will complete this protocol. On day 0, participants will be asked to undergo a bout of unilateral resistance exercise, and the investigators will assess the acute response to exercise + protein feeding (via EAA supplement).
Interventions
Eligibility Criteria
You may qualify if:
- Females 18-30 years
- BMI between 18-28 kg/m2
- ≥2 days per week of structured exercise
- Generally healthy as assessed by medical and physical activity questionnaires
- Participants not currently pregnant
You may not qualify if:
- Any muscular, neurological, respiratory, or metabolic disease including diabetes
- Any form of cancer currently or in the last 5 years
- Bleeding disorders or antiplatelet / anticoagulation therapy
- Currently taking fish oils or within the last 6 months
- Currently taking any form of steroid or within the last 3 months
- Inability to attain magnetic resonance imaging scans
- Known irregular responses to physical activity (e.g., shortness of breath, chest pain, dizziness, etc.)
- Any current illness
- Currently smoking or smoking within the last 6 months
- Currently pregnant
- Any concurrent medical, psychiatric, or orthopedic condition that, subject to investigators' discernment, would negatively affect the subject's ability to comply with the study requirements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School of Kinesiology and Health Studies
Kingston, Ontario, K7L 3N6, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 16, 2024
First Posted
April 5, 2024
Study Start
April 1, 2024
Primary Completion
March 11, 2025
Study Completion
March 11, 2025
Last Updated
October 1, 2025
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share